Abstract
Administration of a standard dose of Rh immune globulin in the immediate postpartum period is adequate to protect 93 per cent of the Rh negative mothers that would otherwise become sensitized. It is now possible by utilizing fetal cell counts to identify those patients in which the standard dose of immune globulin is inadequate for protection. A method for easy and accurate identification of potential failures is described.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
